Skip to main content
European Spine Journal logoLink to European Spine Journal
. 2013 Jun 12;22(12):2787–2799. doi: 10.1007/s00586-013-2850-1

Spinal infection: state of the art and management algorithm

Rui M Duarte 1,2,, Alexander R Vaccaro 3
PMCID: PMC3843785  PMID: 23756630

Abstract

Introduction

Spinal infection is a rare pathology although a concerning rising incidence has been observed in recent years. This increase might reflect a progressively more susceptible population but also the availability of increased diagnostic accuracy. Yet, even with improved diagnosis tools and procedures, the delay in diagnosis remains an important issue. This review aims to highlight the importance of a methodological attitude towards accurate and prompt diagnosis using an algorithm to aid on spinal infection management.

Methods

Appropriate literature on spinal infection was selected using databases from the US National Library of Medicine and the National Institutes of Health.

Results

Literature reveals that histopathological analysis of infected tissues is a paramount for diagnosis and must be performed routinely. Antibiotic therapy is transversal to both conservative and surgical approaches and must be initiated after etiological diagnosis. Indications for surgical treatment include neurological deficits or sepsis, spine instability and/or deformity, presence of epidural abscess and upon failure of conservative treatment.

Conclusions

A methodological assessment could lead to diagnosis effectiveness of spinal infection. Towards this, we present a management algorithm based on literature findings.

Keywords: Spinal infection, Spondylodiscitis, Spondylitis

Introduction

Spinal infection is an ancient entity with some descriptions dating from the Iron age [1]. In 1779, Pott made the first detailed description of tuberculosis infection in the spine, and a century later, Lanneloung, in France, reported for the first time the term pyogenic osteomyelitis of the spine in medical literature [2].

When infection affects the intervertebral disc, the term to describe this condition is usually spondylodiscitis [3]. If invades the endplates or the vertebral body, the infection is more correctly designated for vertebral osteomyelitis or spondylitis [4]. However, at the time of diagnosis in many cases, the infection has already compromised these two structures; therefore, both terms are frequently used [3].

Due to the low specificity of signs and symptoms at clinical presentation, a significant delay usually occurs until the establishment of diagnosis and treatment. Literature data report a delay of 2–6 months between first symptoms and diagnosis [3, 5, 6], leading in some cases to catastrophic outcomes.

In this paper, we propose an algorithm for diagnostic assessment as well as current treatment options and their therapeutic outcomes based on an extensive literature review.

Epidemiology

Spine is susceptive to infection, accounting for 2–7 % of all cases of musculoskeletal infections [7]. Its incidence varies between 1:100,000 and 1:250,000 in developed countries and its estimated mortality rate ranges between 2 and 4 % [3, 5]. Numerous studies refer to a bimodal distribution with a peak below 20 years and another between 50 and 70 years of age, representing in this group, approximately 3–5 % of all cases of osteomyelitis [4, 8]. Furthermore, a 2:1–5:1 male/female ratio has been reported [9, 10].

Known predisposing risk factors include previous spine surgery, a distant infectious focus, diabetes mellitus, advanced age, intravenous drug use, HIV infection, immunosuppression, oncologic history, renal failure, rheumatological diseases, and liver cirrhosis [1113].

In recent years, an increased incidence has been observed, due to a combined effect between an increase in susceptible populations (particularly history of previous spine surgery) and an improved accuracy in diagnosis [14]. Nowadays, postprocedural discitis represents up to 30 % of all cases of pyogenic spondylodiscitis and has been related to almost all spine surgery techniques [15, 16].

Etiology

Spine infections occur by three major agents: bacteria, causing pyogenic infections; tuberculosis or fungi, responsible for granulomatosis infections; or by parasites, which are the less common etiology. In the past, tuberculosis infection was the major cause of spinal infections, however, due to the success on diagnosis and treatment of lung tuberculosis, its incidence has decreased during the last 50 years. Nowadays, the majority of spinal infections are bacterial monomicrobial [17, 18] caused by Staphylococcusaureus with an incidence between 30 and 80 % [4, 14, 18]. Gram-negative bacteria such as Escherichia coli are responsible, in some series, for up to 25 % of spinal infections [4]. Mycobacterium tuberculosis is particularly common in HIV positive patients, reaching in this susceptive group up to 60 % of identified pathogens. Anaerobic agents are also a cause of infections, especially in penetrating spine trauma [19]. Despite the efforts to identify the infectious agent, one-third of these have never been identified [20, 21]. However, particular attention should be given to some endemic areas such as Eastern Europe and Mediterranean countries, where both brucellosis and tuberculosis still have a high incidence [22]. Turunc et al. [23], in a prospective study including a total of 75 spondylodiscitis patients, found that 13 of them (17.3 %) were caused by tuberculosis, 32 (42.7 %) by brucellosis, and 30 (40 %) by other bacterial agents.

Pathophysiology

Classically, there are three routes of pathogen spread: hematogenous, direct external inoculation, and spread from contiguous tissues.

In children, the intraosseous arteries have extensive anastomosis with some vessels penetrating the intervertebral disc [24]. For this reason, a septic embolus from hematogenous spread does not cause bone infarction, and the infection is located essentially within the disc. The adult intervertebral disc is avascular and undergoes, around the third decade of life, an involution of the intraosseous anastomosis [25]. Therefore, as the adult ages, the release of septic emboli leads to the formation of extensive vascular bone infarcts and spread of infection to adjacent structures leading to the classic spondylodiscitis imaging: erosion of vertebral endplates, osteolytic lesions, and compression fractures, which can lead to spine instability, deformity, and risk of spinal cord compression [25, 26]. An infection can lead to an uncontrolled spread beyond the bone structures and access the surrounding tissues, causing paravertebral and psoas abscesses. When spreading into the spinal canal, it can cause epidural abscesses, subdural abscesses, and meningitis. Spreading to the posterior structures is very rare because of its deficit vascular supply and occurs more frequently in fungal and tuberculosis spondylodiscitis [25].

Pyogenic spondylodiscitis caused by hematogenous spread affects mainly the lumbar spine (58 %), followed by thoracic (30 %) and cervical (11 %) [25, 27], reflecting to some extent the vascular supply of these structures. Tuberculosis lesions preferentially affect the thoracic spine, often involving more than two levels, which differentiates it from pyogenic spondylodiscitis [27]. Direct inoculation pathway is frequently iatrogenic: postsurgical lumbar procedures, after lumbar puncture or epidural procedures [15]. Contiguous spread is rare and may occur in the context of adjacent infection, including esophageal ruptures, retropharyngeal abscesses, or infections of aortic implants [28].

Diagnosis

Clinical findings

Diagnosis is generally difficult and requires a high level of suspicion. For this reason, a significant delay usually occurs between the first symptoms and diagnosis. This diagnosis should be supported by clinical, laboratory, and imaging findings (Fig. 1) [3, 5].

Fig. 1.

Fig. 1

Spinal infection management algorithm: step 1. ESV erythrocyte sedimentation velocity, CRP C-reactive protein, WBC white blood cell count, MRI Magnetic resonance imaging

Nonspecific back or neck pain are generally the first clinical features, however, up to 15 % of patients could be pain free [12]. With this insidious onset, patients have constant pain that worsens at night, often associated with radicular pain to the chest or abdomen [14]. Fever is less common [29] occurring in about 48 % of patients with pyogenic spondylodiscitis and in about 17 % of tuberculosis spondylitis cases. Dysphagia and torticollis are symptoms that may be caused by cervical location [30].

Symptoms associated with neurological deficits, such as leg weakness, numbness, and incontinence, are present in about one-third of patients [9]. These are often associated with late diagnosis [31], cervical infection [30], presence of epidural abscess, tuberculosis infection [32], and late diagnosis. During physical examination, it is important to look for kyphosis deformities, swelling, and tumefactions, which are often associated with tuberculosis spondylitis [33]. Yet, it has been recognized a frequent association of pyogenic vertebral osteomyelitis and infectious endocarditis. Pigrau et al. [31] found among 91 cases of pyogenic vertebral osteomyelitis, 28 of them (30.8 %) had infectious endocarditis. This should not be underestimated during clinical evaluation: in patients with Gram-positive infections and cardiac infection risk, or symptoms such as new heart murmur, peripheral stigmata, or other metastatic foci; it is strongly recommended to perform an echocardiography [34, 35].

In pediatric ages, clinical presentation is very nonspecific. Symptoms may include irritability, refusal to crawl, sit or walk, abdominal pain, or incontinence [36, 37]. Fever is rare in children [37], and the most frequent sign found on physical examination is the loss of lumbar lordosis [38]. Development of neurological deficits is extremely rare [36].

Laboratory findings

There are several markers routinely used in clinical practice that are critical for diagnosis and further evaluation of treatment response [39]. Erythrocyte sedimentation rate (ESR) is a sensitive marker of infection, yet with low specificity. Furthermore, ESR is also used as a marker of therapeutic response, for instance, Carragee et al. [39] found that a 25 % reduction of its initial value after 1 month of treatment was a good prognosis marker. However, in 9/18 (50 %) of those with no change in the ESR had good outcome [39]. Thus, in patients responding to therapy, a raised ESR should not lead to unnecessary invasive procedures and/or prolonged therapy. The C-reactive protein (CRP) is also elevated in more than 90 % of spondylodiscitis cases [17, 40], and some authors consider this marker the best monitor of treatment response, once it returns to normal after adequate treatment and faster than ESR [41, 42]. The WBC (white blood cells) count is the least useful of all inflammatory markers, due to its low sensitivity [17, 40].

Once a spinal infection is suspected, it is recommended to obtain blood and urine cultures before antibiotic initiation [21, 43]. According to the main monomicrobial pattern of pyogenic spondylodiscitis, about up to 59 % of positive blood cultures identify the causative microorganism [4]. Aerobic cultures are performed routinely, while anaerobic were discouraged in the late 80s due to decreasing incidence of anaerobic bacteremia. Consequently, nowadays not all centers are capable to perform anaerobic cultures. Unfortunately, anaerobic bacteremia has reemerged as a significant clinical problem and its detection is highly recommended once it increases positive rate of blood cultures [44, 45].

Despite a suspicious history, associated positive blood cultures, and imaging findings consistent with a clinical diagnosis of spinal infection, the definitive diagnosis only can be achieved by microscopic or bacteriological examination of the infected tissues. Several reports emphasize its importance in patients whose blood cultures were negative or inconclusive [17, 18, 23, 46]. However, due to the fact that biopsy is superior to blood cultures in pathogen detection, we routinely perform biopsies in suspicious cases (Fig. 2). Gasbarrini et al. [47] published recently a comparative study where they conclude that percutaneous CT-guided needle biopsy is the mainstay of diagnosis for spinal lesions of unknown etiology and its accuracy has been reported up to 70 %. Nevertheless, the diagnostic yield of CT-guided needle biopsy is variable between centers, depending on the expertise of the radiologist, the number of samples sent, and the absence of previous antibiotic therapy; thus some authors reserve open biopsies for cases with CT-guided negative cultures [27]. Regarding our personal experience, in cases of patients with absolute indication for surgical treatment, open biopsy is our first choice as biopsy method once allows a greater amount of tissue to be harvested. Higher tissue yield and consequently more specific results are obtained than with percutaneous CT‐guided needle biopsy (Fig. 2). For those without criteria for surgery and given the importance of histological diagnosis, CT-guided biopsy is a true option. The role of biopsy in children is not consensual. Some authors recommend it routinely, while others defend its performance only in cases of refractory to empirical treatment or in suspected fungal or mycobacterial infection [36, 48]. The specimens should be submitted to microbiological analysis, such as Gram smear, aerobic and anaerobic cultures, and fungal culture particularly for tuberculosis infections, AFB smear, polymerase chain reaction, and tuberculosis culture. Once Mycobacterium tuberculosis grows slowly (6–8 weeks [49]), a valuable aid for a faster diagnosis is the use of interferon-gamma release assays (IGRA) measured from whole blood plasma, providing results in less than 24 h. In addition, according to Kumar et al. [50], in a study with 70 patients followed for spinal TB infection, the sensitivity of the AFB smear and culture (together) was 59 % and the further addition of IGRA data resulted in a sensitivity of 88 %. Histopathology, per se, has a complementary value to microbiological culture in distinguishing pyogenic from granulomatous diseases [5153] and is mandatory if tumor lesions are suspected [5456].

Fig. 2.

Fig. 2

Spinal infection management algorithm: step 2. *Antibiotic is adjusted according to the subsequent bacterial culture results

Imaging

Plain radiographs should be performed in an initial evaluation for suspected pathology of the spine. Although it has low specificity (57 %) in spondylodiscitis diagnosis, it will reveal, in advanced cases, irregularity of vertebral endplates with eventual fragmentation and low intervertebral disc height [57]. It is also important to identify any coronal or sagittal malalignment resulting from the disease process.

Computed tomography (CT) remains the best test for evaluation of bony changes, including early changes of vertebral endplates, the presence of bone necrosis, and pathological calcifications suggestive of tuberculosis [57]. CT is also routinely used in percutaneous CT-guided needle biopsy [5153].

Magnetic resonance imaging (MRI) is considered the gold standard modality for spondylodiscitis imaging diagnosis [5860] due to its high sensitivity (96 %), specificity (94 %), and greater capacity to provide detailed anatomical information about surrounding soft tissues and epidural space [59]. The characteristic changes consist of a hypointense signal of the disc and vertebral body on T1-weighted images and a hyperintense signal of the same structures (due to edema) on T2-weighted images. Gadolinium enhancement of the intervertebral disc, vertebral body, and surrounding soft tissues increases the accuracy of MRI, especially when other changes are subtle and also help in the differentiation of infectious lesions from degenerative (T2 hypointensity favoring Modic endplate changes) and tumor lesions (T1 hypointense relatively to normal bone marrow) [61, 62]. MRI also plays an important role in the distinction between tuberculosis spondylitis and pyogenic spondylodiscitis [63]. Tuberculosis spondylitis has an extensive bone destruction pattern with relative sparing of the intervertebral disc, heterogeneous enhancement of the vertebral body, and large paravertebral abscesses. Table 1 summarizes several imaging features that can strongly support differential diagnosis of spinal infection etiologies.

Table 1.

Imaging features that can strongly support differential diagnosis of spinal infection etiologies [23, 61, 6870]

Pyogenic Tuberculous Brucellar Fungal
Spine segment Lumbar Thoracic/thoracolumbar junction Lower lumbar Lumbar
Vertebral body (VB) Early stage: anterior aspect of VB classically VB T1 hypo- and endplate T2 hyperintensity
Late stage: VB destruction; T2 hyperintensity and homogeneous enhancement; Adjacent VB involvement
Early stage: anterior aspect of VB three patterns: para discal (more common)—discal involvement and contiguous spread to adjacent VB, T1 hypointensity and T2 heterogenous hyperintensity. Anterior—anterior scalloping of VB and large subligamentous abcesses Central—vertebra plana deformity; IVD not involved
Late stage: T1 variable intensity with bone healing
Relatively preserved VB Involvement: serrated margins of vertebral endplates without severe VB destruction
Disc space involvement Present: early stage involvement T2 hyperintensity and enhancement Variable: from disc space sparing up to severe destruction Present Typically spared; lack of T2 hyperintensity
Paraspinal/epidural space involvement If present: inflammation and/or small abscesses with thick and irregular rim enhancement Present: large paraspinal abscesses; thin and smooth rim enhancement Typically not present: lack of paraspinal abscess Present: Small paraspinal abscesses thick and irregular rim enhancement
Posterior elements Typically not involved Can be involved Typically not involved Can be involved Rib heads also
Anterior subligamentous spread Uncommon Present: can be more extensive than the vertebral involvement Uncommon Common
Adjacent vertebral levels involvement Present: endplate destruction Present: high bone destruction Uncommon Uncommon
Multilevel involvement Uncommon Common: skip lesions Uncommon Common: skip lesions

Nevertheless, once different appearances occur at different stages, there is no pathognomonic finding on MRI that reliably distinguishes among spinal infections etiologies or from a possible neoplasm. Therefore, we emphasize the importance of complementary diagnosis methods (Figs. 1, 2—Spinal infection management algorithm).

Kowalski et al. [64] suggest that certain MRI findings may persist or even worsen during treatment, despite the clinical improvement, and may lead to unnecessary invasive treatments. Changes compatible to resolution of the infection appear later and consist in the loss of gadolinium uptake and restoration of bone. Therefore, despite the increasing use of follow-up MR imaging to monitor response to treatment in patients with spinal infection, the study of Kowalski does not support the routine use of follow-up MR imaging in patients who are clinically responding to therapy [64, 65].

Sequential bone/gallium imaging and 67 Ga-SPECT are currently the radionuclide procedures of choice for spinal infections, but the observed lack of specificity have lead to an increase interest in [18F]Fluoro-2-deoxy-d-glucose (FDG) PET, as a promising technique in the absence of spinal instrumentation as degenerative changes and fractures usually do not produce intense FDG uptake [66, 67]. Despite its increasing importance, radionuclide imaging in spinal infections should be reserved for cases of uncertain diagnosis or when MRI is inconclusive.

Treatment

The key principles for successful treatment of spinal infections are antibiotic therapy for eradication of the underlying infection; fixation of the affected segment to preserve or restore the spinal structure and stability; and debridement and decompression of the spinal canal in the presence of neurological deficits or epidural abscesses [4, 71].

Spine infections are infrequently emergency situations at presentation and for this reason, antibiotic therapy should be initiated only after a definitive etiologic diagnosis (Fig. 2).

In the presence of sepsis or the impossibility of an etiologic diagnosis, empirical antibiotic therapy should be considered. The antibiotic spectrum must be extended to cover S. aureus and E. coli, the commonest pathogens for pyogenic spondylodiscitis, and obviously take into account the local epidemiology and the possibility of colonization by resistant organisms [4]. In cases of bacteremia caused by methicillin-resistant S. aureus (MRSA), the drug of choice is usually vancomycin; however, its efficacy is doubtful. To ensure therapeutic concentration levels in the bone, the American Society of Infectious Diseases (ASID) recommends maintaining vancomycin concentrations above 15–20 mg/L.

In confirmed tuberculosis spondylitis, specific tuberculostatic therapy should be initiated. The guidelines from British infection society (BIS) recommends that the treatment of all forms of central nervous system (CNS) tuberculosis should consist of four drugs (isoniazid, rifampicin, pyrazinamide, ethambutol) for 2 months followed by two drugs (isoniazid, rifampicin) for at least 10 months [72]. In atypical infections, a consensual therapeutic regime has not been yet established [4].

Regarding fungal spondylodiscitis, it is generally difficult to identify the fungal agent, and antimycotic therapy is often complicated. Although there is no consensus in the literature, man authors recommend surgery as first approach [4, 71, 73].

The literature provides no clear guidance regarding the duration and route of administration of antibiotic therapy. Generally, an initial parenteric administration is advised, during a range of 3–8 weeks period [74]. Long duration therapy has not been directly related to better outcomes. For instance, Roblot et al. [34], in a retrospective study of 120 patients, found no difference in the risk of relapse amongst patients treated for 6 weeks or longer. After this initial period, antibiotic therapy could follow on with oral administration based on individual response and type of pathogen involved. In nonspecific pyogenic spondylodiscitis, oral antibiotic therapy is recommended for an additional period of 6 weeks to 3 months [4, 5]. Given the high bioavailability and good diffusion of fluoroquinolones, clindamycin, rifampicin, and fusidic acid, some reports indicate exclusively oral antibiotherapy, avoiding the inconveniences of parenteric treatment [34, 75]. In addition, due to these facts, an early conversion from parenteric to oral therapy can be performed. In this scenario, before early oral conversion, endocarditis must be excluded [31]. In tuberculosis spondylitis, the treatment should be continued for a period of 10–24 months, to allow adequate healing and prevent recurrence [4].

It has been proposed that a weekly reduction of 50 % in CRP is suggestive of a favorable evolution, and accepted criteria for discontinuing the antimicrobial treatment includes improvement or resolution of the symptoms and normalization of ECR or CRP [76].

Conservative treatment

In patients without a formal indication for surgery (neurological deficits, spine instability, and intractable pain) or with high surgical risk, conservative treatment is a real valid option [4, 18, 23].

The controversy arises in the presence of minor neurological deficits [31, 77, 78]. In Pigrau et al. series, only 13 % of the patients required surgery, even though 29.7 % of patients had neurologic symptoms. In our opinion, the conservative approach in this particular scenario is desirable if there is no spinal instability. Neurological symptoms are minor and expected to improve with specific antibiotic therapy.

Immobilization is one of the milestones of a successful conservative approach. The immobilization of the affected segment is necessary when pain is significant and there is no risk of instability. It also eliminates the need for prolonged bed rest. Cervical spine immobilization can be achieved using a collar or a halo-fixator. For the thoracic or lumbar spine, a thoracolumbar brace allows the load distribution to the unaffected joints and reduce the pressure on the affected vertebra [4, 18]. Known risks related to immobilization include up to 50 % non-union rate at an involved disc, which may lead to kyphosis deformity and chronic pain syndrome [3]. If a patient demonstrates increasing pain and deformity in spite of improvement of laboratory indices, then surgical management should be considered.

Even with a conservative approach, the CT-guided percutaneous drainage can be effective for patients with pyogenic spondylodiscitis and a secondary psoas abscess.

Surgical management

Early surgical treatment should be performed in the presence of neurological deficits or sepsis [18]. Absolute surgical indications also include spinal instability due to extensive bone destruction, severe kyphosis, intracanal spinal lesion with mass effect, unknown etiologies associated with active tumor, and in failure of conservative treatment [4, 79]. Some authors also recommend surgical treatment in the presence of epidural abscess even without associated neurological deficits, especially in the cervical and thoracic region [80]. The relative indications consist of the presence of uncontrolled pain and inexistent conditions for conservative treatment [5].

Despite indication for surgery in the presence of neurological deficits, age and presence of concurrent medical conditions may affect surgical decision [20]. According to Yoshimoto et al. [81] in a review of 45 cases of pyogenic spondylitis in elderly, 42 % of patients with paralysis on admission were not submitted to surgery due to poor general condition. Yet, paralysis was improved in 73 % of these patients with conservative treatment [81].

The main goals of surgical treatment of spinal infections include (1) early decompression of the spinal canal and stabilization of the involved vertebral segment, in the presence of neurological deficits [3, 4, 82, 83]; (2) aggressive tissue debridement, including drainage of paravertebral abscesses; and (3) sample harvesting for microbiological and histological analyses.

Regarding the surgical strategy itself, recommendations are controversial [3, 84]. Any standard approach can be used (anterior, posterior, combined, or minimally invasive approaches), whereas the choice is related mainly to the presence of neurological deficits, the location of the infection, and degree of associated bone destruction (Table 2).

Table 2.

Summary of the most relevant features of spinal infections’ surgical treatment—clinical series published in the last 5 years

Reference Number of patients Follow-up (M) Neurologic deficitis (%) Etiology Spine segment Surgical approach Anterior reconstruction Mortality (%) Neurologic improvement (%) Union rate (%) Loss of correction
Zhang et al. 2012 [87] 14 50.1 (42–64) 100.0 TB Lumbar Combined (two-staged) Allograft (fresh frozen ICBG) 0 100.0 100.0 1.9°
Shousha et al. 2012 [88] 30 28.4 (6–54) 40.0 PY Cervical Single anterior (17)
Combined (13)
CAGE (17)
Autologous ICBG (10)
10 58.0 100.0 (–)
Masuda et al. 2011 [89] 30 26.2 (3–60) 90.0 PY (19)
TB (11)
TL Combined (two-staged) Bone graft 0 56.7 100.0 (–)
Koptan et al. 2011 [90] 30 66 (24–84) 60.0 TB Cervical Single anterior CAGE (16)
Autologous ICBG (14)
0 94.4 93.0 (–)
Erturer et al. 2010 [91] 20 52.7 (37–94) 55 TB TL Combined (single-staged) CAGE (allgograft) 0 90.9 100 0.8°
Chen et al. 2010 [92] 16 24 (–) 31.3 PY (10)
TB (1)
Lumbar Single anterior (12)
Combined (4)
Autologous ICBG 12.5 80.0 85.7
Hempelmann et al. 2010 [93] 18 21 (12–42) 38.9 PY Lumbar Posterior (PLIF) Autologous ICBG 17 100.0 100.0 (–)
Hirakawa et al. 2010 [94] 10 48.2 (24–101) 60.0 TB Lumbar Combined (two-staged) Autologous bone 0 66.7 100.0 5.1°
Okada et al. 2009 [95] 52 35.9 (24–120) 80.8 PY (25)
TB (27)
Cervical
TL
Single anterior (15)
Posterior (7)
Combined (30)
(–) 0 90.4 (–) 1.9° PY
2.4° TB
Zaveri et al. 2009 [96] 15 41 (26–69) 86.7 TB Lumbar Posterior (PLIF) CAGE (autologous bone) 0 100.0 86.7
Lu et al. 2009 [97] 36 21 (10–39) 72.2 PY (30)
TB (6)
Cervical
TL
Combined (27)
Single anterior (5) Posterior (4)
CAGE (autograft or allograft) 2.7 92.0 (–) (–)
Robinson et al. 2008 [98] 22 36 (32–47) 22.7 PY (12)
TB (1)
Cervical
TL
Single anterior (3)
Combined (19)
CAGE (autologous bone) 9 (–) 100.0 3.7°
Pee et al. 2008 [99] 60 35.8 (26–50) 26.7 PY Lumbar Combined (single-staged) CAGE (37)
Autologous ICBG (23)
0 68.7 95.0 (–)
Korovessis et al. 2008 [100] 24 56 (31–116) 58.3 PY (20)
BC (4)
Cervical
TL
Combined (single-staged) CAGE (autologous bone) 0 85.6 100.0 0.6°

TB tuberculous, PY pyogenic, TL thoracolumbar, PLIF posterior lumbar interbody fusion, ICBG iliac crest bone graft

In cervical spinal infections, an anterior approach is recommended with appropriate debridement, decompression (eventual corpectomy), and fusion with bone graft, associated with anterior plate stabilization. In multilevel intervention, this should be complemented with posterior instrumentation [82]. Eventually, if the involvement was mainly epidural with no severe destruction of the vertebral body, it is acceptable to proceed toward posterior decompression and fusion [71, 82].

In the thoracic spine, as stability is maintained mostly by the rib cage and with physiologically restricted mobility, stability issues may not be a significant priority. Therefore, in the presence of an epidural involvement without anterior disc or bony destruction, a posterior approach with decompression and instrumentation is usually the first option. A purely anterior approach for decompression and fusion (using a transthoracic, posterolateral, or thoracoscopic approaches) is reserved for monosegmental lesions without involvement of posterior elements [85]. Even in this situation, consideration for adjunctive posterior stabilization is often considered. In advanced anterior bone destruction and collapse, it is recommendable an anterior approach for debridement, decompression, and fusion with bone graft complemented with additional posterior instrumentation [71, 82, 83].

At the thoracolumbar juncture, decompression and stabilization are recommended in the presence of a neurological deficit or extensive epidural invasion. In cases of monosegmental spondylodiscitis with moderate anterior bone involvement and minimal kyphosis deformity, a posterior lumbar interbody fusion may be sufficient [86]. Many surgeons prefer, however, not to invade the posterior tissues with exposure to purulent tissue and would prefer an initial anterior debridement followed by a posterior stabilization procedure.

In the presence of an extensive anterior bone destruction and collapse with segmental kyphosis, a double approach (performed in one or two stages) with anterior debridement and interbody fusion associated with posterior instrumentation results in faster fusion, improved correction of the kyphotic deformity and its maintenance, as well as earlier patient mobilization [18, 101103]; yet, opinions diverge about the best option for anterior interbody fusion (Table 2). Classically, bone grafting with tricortical iliac autograft is recognized as a safe procedure, with excellent and consistent outcomes [103105]. Structural bone allograft can be used as an alternative, avoiding donor site morbidity and reducing operative time [97]. Furthermore, recent publications have demonstrated improved fusion rates when combining recombinant human bone morphogenic protein-2 (rhBMP-2) with structural bone graft [106108]. A drawback that surgeons must keep in mind when using bone allografts, although not frequent, is the risk of provoking an immune reaction or that it could become a source for infection transmission [103].

Structural bone grafting persists as a standard procedure in several centers, majorly due to the concern about risks of introducing hardware in an infected field [109]. Nevertheless, several recent publications show that metallic implants can be safely used in spinal infections (Table 2) [9698, 100, 109112]. Despite the importance in distinguishing the different risks of using metallic implants in pyogenic or tuberculous infection, enthusiastic outcomes have been published on the use of hardware in both cases. Erturer et al. [91], in a series of 20 patients with tuberculous spondylitis submitted to anterior interbody fusion using titanium mesh cage, reported solid fusion in all patients with maintenance of kyphosis correction, as well as no recurrence of tuberculosis infection [91]. Regarding pyogenic spondylodiscitis, Liljenqvist et al. [102] reported a 100 % fusion rate and infection eradication in a 20-patient series with destructive vertebral osteomyelitis treated by a double approach with anterior column reconstruction using an expandable titanium cage filled with morselized autologous bone graft [102].

With the advent and development of minimally invasive spine surgery (MISS), some techniques have been used successfully in the treatment of spinal infection. At the thoracic segment, thoracoscopic approach has been used in some centers with exciting results and additional advantages such as pain reduction and improved postoperative respiratory function, less damage to the soft tissues, resulting in improved esthetic results, and shorter hospital stay [85]. In the lumbar segment, posterior percutaneous instrumentation is already regularly used in patients who underwent double approach.

Prognosis

With the advent of antibiotics, improved techniques of management, and early recognition, mortality associated with spinal infections has significantly decreased to <5 % in developed countries [12, 20, 21], and early mortality is generally related to uncontrolled sepsis. Despite mortality has declined, the most worrying outcome is the potential for a permanent neurological deficit.

Some retrospective outcome studies present distinct prognostic factors. We summarized those related to a poor outcome in Table 3. Besides age and spine segment, underlying conditions that are associated with poor prognosis, the major prognostic factor was the presence of a motor deficit before treatment and if the neurological deficits are present for longer than 36 h [5, 18]. In our opinion, whenever these patients gather surgical conditions, an operative approach might greatly improve prognosis. In a series by Hadjipavlou et al. [18], 23 % of patients with paralysis on admission recovered completely after surgical decompression.

Table 3.

Spinal infections’ prognostic factors associated with poor outcomes

Prognostic factor Poor outcome References
Age Older patients [114116]
Spinal segment Cervical/thoracic involvement [20, 117119]
Underlying disease Diabetes mellitus [114, 116]
Chronic heart disease [114]
Clinical presentation Paralysis [20, 80, 113, 115, 118120]
Bowel/bladder disfunction [115, 118, 120]
Diagnosis Delayed [118, 119, 121]
Pathogen MRSA [20, 116]
Length of time for surgery >36 h [5, 18, 80, 113, 120, 122]

Despite the presence of neurological deficits on admission, at medium- and long-term follow-up, residual symptoms persist independently of treatment choice and this detrimental outcome is directly related with diagnosis delay [113]. These sequelae are essentially the result of degenerative changes secondary to tissue destruction by the infectious process. McHenry et al. [76] reported in a 253 patients follow-up series, 14 % of patients had a recurrence of their infection of which 75 % occurred in the first year after surgery. In childhood, the prognosis is excellent [36, 48].

Conclusions

Spinal infections remain a rare pathology, although an increased incidence has been reported due to a progressively more susceptible population (particularly history of previous spine surgery and HIV positive populations) and improved diagnostic acuity.

Due to the insidious onset, a high clinical suspicion remains the centerpiece of a prompt diagnosis, which is pivotal to improve long-term outcomes and prevent permanent neurologic deficits. Herein, microbiological and histological diagnosis plays a critical role toward the definition of specific therapeutic management. Therefore, in CT-guided or open biopsy should be considered a first line of investigation in suspected cases.

The treatment of spinal infections is mainly a nonsurgical treatment and comprises a specific antibiotic therapy associated with immobilization that reduces pain and helps preventing segmental instability and deformity. Surgery is indicated for patients with neurological deficits or sepsis, spine instability and/or deformity, presence of epidural abscess, and in failure of conservative treatment. Once spinal infections affect mainly the vertebral body and the intervertebral disc, surgical strategy should include appropriate anterior debridement of the infected tissues and reconstruction of the involved segments with bone construct, posterior decompression of neural elements, and instrumented stabilization. In selected patients, MISS has been used and is showing interesting results.

Acknowledgments

Special acknowledgments to Professor António Oliveira and Dr. Jorge Seabra (Hospital Geral de Santo António, Porto) and Dr. Pedro Varanda (Hospital de Braga, Braga) for their contributions to the manuscript.

Conflict of interest

None.

References

  • 1.Tayles N, Buckley HR. Leprosy and tuberculosis in iron age southeast Asia? Am J Phys Anthropol. 2004;125(3):239–256. doi: 10.1002/ajpa.10378. [DOI] [PubMed] [Google Scholar]
  • 2.Camillo FX. Infections of the spine. In: Canale ST, Beaty JH, editors. Campbell’s operative orthopaedics. Philadelphia: Mosby Elsevier; 2008. [Google Scholar]
  • 3.Frangen TM, et al. Surgical management of spondylodiscitis. An analysis of 78 cases. Unfallchirurg. 2006;109(9):743–753. doi: 10.1007/s00113-006-1084-7. [DOI] [PubMed] [Google Scholar]
  • 4.Sobottke R, et al. Current diagnosis and treatment of spondylodiscitis. Dtsch Arztebl Int. 2008;105(10):181–187. doi: 10.3238/arztebl.2008.0181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Butler JS, et al. Nontuberculous pyogenic spinal infection in adults: a 12-year experience from a tertiary referral center. Spine (Phila Pa 1976) 2006;31(23):2695–2700. doi: 10.1097/01.brs.0000244662.78725.37. [DOI] [PubMed] [Google Scholar]
  • 6.Tsiodras S, Falagas ME. Clinical assessment and medical treatment of spine infections. Clin Orthop Relat Res. 2006;444:38–50. doi: 10.1097/01.blo.0000203454.82264.cd. [DOI] [PubMed] [Google Scholar]
  • 7.Tyrrell PN, Cassar-Pullicino VN, McCall IW. Spinal infection. Eur Radiol. 1999;9(6):1066–1077. doi: 10.1007/s003300050793. [DOI] [PubMed] [Google Scholar]
  • 8.Krogsgaard MR, Wagn P, Bengtsson J. Epidemiology of acute vertebral osteomyelitis in Denmark: 137 cases in Denmark 1978–1982, compared to cases reported to the National Patient Register 1991–1993. Acta Orthop Scand. 1998;69(5):513–517. doi: 10.3109/17453679808997789. [DOI] [PubMed] [Google Scholar]
  • 9.Mylona E, et al. Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics. Semin Arthritis Rheum. 2009;39(1):10–17. doi: 10.1016/j.semarthrit.2008.03.002. [DOI] [PubMed] [Google Scholar]
  • 10.Grammatico L, et al. Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002–2003. Epidemiol Infect. 2008;136(5):653–660. doi: 10.1017/S0950268807008850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Carragee EJ. Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am. 1997;79(6):874–880. doi: 10.2106/00004623-199706000-00011. [DOI] [PubMed] [Google Scholar]
  • 12.Fantoni M, et al. Epidemiological and clinical features of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci. 2012;16(Suppl 2):2–7. [PubMed] [Google Scholar]
  • 13.Afshar M, Reilly RF. Spondylodiscitis in a patient on chronic hemodialysis. Nat Rev Nephrol. 2011;7(10):599–604. doi: 10.1038/nrneph.2011.105. [DOI] [PubMed] [Google Scholar]
  • 14.Jensen AG, et al. Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980–1990. J Infect. 1997;34(2):113–118. doi: 10.1016/s0163-4453(97)92395-1. [DOI] [PubMed] [Google Scholar]
  • 15.Silber JS, et al. Management of postprocedural discitis. Spine J. 2002;2(4):279–287. doi: 10.1016/s1529-9430(02)00203-6. [DOI] [PubMed] [Google Scholar]
  • 16.Jimenez-Mejias ME, et al. Postoperative spondylodiskitis: etiology, clinical findings, prognosis, and comparison with non-operative pyogenic spondylodiskitis. Clin Infect Dis. 1999;29(2):339–345. doi: 10.1086/520212. [DOI] [PubMed] [Google Scholar]
  • 17.Euba G, et al. Long-term clinical and radiological magnetic resonance imaging outcome of abscess-associated spontaneous pyogenic vertebral osteomyelitis under conservative management. Semin Arthritis Rheum. 2008;38(1):28–40. doi: 10.1016/j.semarthrit.2007.08.007. [DOI] [PubMed] [Google Scholar]
  • 18.Hadjipavlou AG, et al. Hematogenous pyogenic spinal infections and their surgical management. Spine (Phila Pa 1976) 2000;25(13):1668–1679. doi: 10.1097/00007632-200007010-00010. [DOI] [PubMed] [Google Scholar]
  • 19.Lim MR, Lee JY, Vaccaro AR. Surgical infections in the traumatized spine. Clin Orthop Relat Res. 2006;444:114–119. doi: 10.1097/01.blo.0000203448.44146.b1. [DOI] [PubMed] [Google Scholar]
  • 20.Govender S. Spinal infection. J Bone Joint Surg Br. 2005;87 (B):1454–1458. doi: 10.1302/0301-620X.87B11.16294. [DOI] [PubMed] [Google Scholar]
  • 21.Sapico FL. Microbiology and antimicrobial therapy of spinal infections. Orthop Clin North Am. 1996;27(1):9–13. [PubMed] [Google Scholar]
  • 22.Colmenero JD, et al. Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases. Ann Rheum Dis. 1997;56(12):709–715. doi: 10.1136/ard.56.12.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Turunc T, et al. A comparative analysis of tuberculous, brucellar and pyogenic spontaneous spondylodiscitis patients. J Infect. 2007;55(2):158–163. doi: 10.1016/j.jinf.2007.04.002. [DOI] [PubMed] [Google Scholar]
  • 24.Ratcliffe JF. An evaluation of the intra-osseous arterial anastomoses in the human vertebral body at different ages. Microarteriographic Study. J Anat. 1982;134(Pt 2):373–382. [PMC free article] [PubMed] [Google Scholar]
  • 25.Ratcliffe JF. Anatomic basis for the pathogenesis and radiologic features of vertebral osteomyelitis and its differentiation from childhood discitis. A microarteriographic investigation. Acta Radiol Diagn (Stockh) 1985;26(2):137–143. doi: 10.1177/028418518502600204. [DOI] [PubMed] [Google Scholar]
  • 26.Wiley AM, Trueta J. The vascular anatomy of the spine and its relationship to pyogenic vertebral osteomyelitis. J Bone Joint Surg Br. 1959;41-B:796–809. doi: 10.1302/0301-620X.41B4.796. [DOI] [PubMed] [Google Scholar]
  • 27.Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010;65 Suppl 3:iii11–iii24. doi: 10.1093/jac/dkq303. [DOI] [PubMed] [Google Scholar]
  • 28.Babinchak TJ, Riley DK, Rotheram EB., Jr Pyogenic vertebral osteomyelitis of the posterior elements. Clin Infect Dis. 1997;25(2):221–224. doi: 10.1086/514529. [DOI] [PubMed] [Google Scholar]
  • 29.Kim CJ, et al. A comparative study of pyogenic and tuberculous spondylodiscitis. Spine (Phila Pa 197) 2010;35(21):E1096–E1100. doi: 10.1097/BRS.0b013e3181e04dd3. [DOI] [PubMed] [Google Scholar]
  • 30.Schimmer RC, et al. Osteomyelitis of the cervical spine: a potentially dramatic disease. J Spinal Disord Tech. 2002;15(2):110–117. doi: 10.1097/00024720-200204000-00004. [DOI] [PubMed] [Google Scholar]
  • 31.Pigrau C, et al. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome. Am J Med. 2005;118(11):1287. doi: 10.1016/j.amjmed.2005.02.027. [DOI] [PubMed] [Google Scholar]
  • 32.Turgut M. Spinal tuberculosis (Pott’s disease): its clinical presentation, surgical management, and outcome. A survey study on 694 patients. Neurosurg Rev. 2001;24(1):8–13. doi: 10.1007/pl00011973. [DOI] [PubMed] [Google Scholar]
  • 33.Chang MC, et al. Tuberculous spondylitis and pyogenic spondylitis: comparative magnetic resonance imaging features. Spine (Phila Pa 1976) 2006;31(7):782–788. doi: 10.1097/01.brs.0000206385.11684.d5. [DOI] [PubMed] [Google Scholar]
  • 34.Roblot F, et al. Optimal duration of antibiotic therapy in vertebral osteomyelitis. Semin Arthritis Rheum. 2007;36(5):269–277. doi: 10.1016/j.semarthrit.2006.09.004. [DOI] [PubMed] [Google Scholar]
  • 35.Zimmerli W. Clinical practice. Vertebral osteomyelitis. N Engl J Med. 2010;362(11):1022–1029. doi: 10.1056/NEJMcp0910753. [DOI] [PubMed] [Google Scholar]
  • 36.Garron E, et al. Nontuberculous spondylodiscitis in children. J Pediatr Orthop. 2002;22(3):321–328. [PubMed] [Google Scholar]
  • 37.Fernandez M, Carrol CL, Baker CJ. Discitis and vertebral osteomyelitis in children: an 18-year review. Pediatrics. 2000;105(6):1299–1304. doi: 10.1542/peds.105.6.1299. [DOI] [PubMed] [Google Scholar]
  • 38.Brown R, et al. Discitis in young children. J Bone Joint Surg Br. 2001;83(1):106–111. doi: 10.1302/0301-620x.83b1.10865. [DOI] [PubMed] [Google Scholar]
  • 39.Carragee EJ, et al. The clinical use of erythrocyte sedimentation rate in pyogenic vertebral osteomyelitis. Spine (Phila Pa 1976) 1997;22(18):2089–2093. doi: 10.1097/00007632-199709150-00005. [DOI] [PubMed] [Google Scholar]
  • 40.Beronius M, Bergman B, Andersson R. Vertebral osteomyelitis in Goteborg, Sweden: a retrospective study of patients during 1990–95. Scand J Infect Dis. 2001;33(7):527–532. doi: 10.1080/00365540110026566. [DOI] [PubMed] [Google Scholar]
  • 41.Hsieh PC, et al. Surgical strategies for vertebral osteomyelitis and epidural abscess. Neurosurg Focus. 2004;17(6):E4. doi: 10.3171/foc.2004.17.6.4. [DOI] [PubMed] [Google Scholar]
  • 42.Kang BU, et al. Surgical site infection in spinal surgery: detection and management based on serial C-reactive protein measurements. J Neurosurg Spine. 2010;13(2):158–164. doi: 10.3171/2010.3.SPINE09403. [DOI] [PubMed] [Google Scholar]
  • 43.Lillie P, et al. Healthcare associated discitis in the era of antimicrobial resistance. J Clin Rheumatol. 2008;14(4):234–237. doi: 10.1097/RHU.0b013e318181addd. [DOI] [PubMed] [Google Scholar]
  • 44.Goldstein EJ. Anaerobic bacteremia. Clin Infect Dis. 1996;23 Suppl 1:S97–S101. doi: 10.1093/clinids/23.supplement_1.s97. [DOI] [PubMed] [Google Scholar]
  • 45.Lassmann B, et al. Reemergence of anaerobic bacteremia. Clin Infect Dis. 2007;44(7):895–900. doi: 10.1086/512197. [DOI] [PubMed] [Google Scholar]
  • 46.Karadimas EJ, et al. Spondylodiscitis. A retrospective study of 163 patients. Acta Orthop. 2008;79(5):650–659. doi: 10.1080/17453670810016678. [DOI] [PubMed] [Google Scholar]
  • 47.Gasbarrini A, et al. Biopsy for suspected spondylodiscitis. Eur Rev Med Pharmacol Sci. 2012;16(Suppl 2):26–34. [PubMed] [Google Scholar]
  • 48.Fucs PM, Meves R, Yamada HH. Spinal infections in children: a review. Int Orthop. 2012;36(2):387–395. doi: 10.1007/s00264-011-1388-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Cheng VC, et al. Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis. J Clin Pathol. 2004;57(3):281–285. doi: 10.1136/jcp.2003.012658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Kumar R, Das RK, Mahapatra AK. Role of interferon gamma release assay in the diagnosis of Pott disease. J Neurosurg Spine. 2010;12(5):462–466. doi: 10.3171/2009.10.SPINE093. [DOI] [PubMed] [Google Scholar]
  • 51.de Lucas EM, et al. CT-guided fine-needle aspiration in vertebral osteomyelitis: true usefulness of a common practice. Clin Rheumatol. 2009;28(3):315–320. doi: 10.1007/s10067-008-1051-5. [DOI] [PubMed] [Google Scholar]
  • 52.Rankine JJ, et al. Therapeutic impact of percutaneous spinal biopsy in spinal infection. Postgrad Med J. 2004;80(948):607–609. doi: 10.1136/pgmj.2003.017863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Michel SC, et al. CT-guided core biopsy of subchondral bone and intervertebral space in suspected spondylodiskitis. AJR Am J Roentgenol. 2006;186(4):977–980. doi: 10.2214/AJR.05.0109. [DOI] [PubMed] [Google Scholar]
  • 54.Fenollar F, Levy PY, Raoult D. Usefulness of broad-range PCR for the diagnosis of osteoarticular infections. Curr Opin Rheumatol. 2008;20(4):463–470. doi: 10.1097/BOR.0b013e3283032030. [DOI] [PubMed] [Google Scholar]
  • 55.Fuursted K, et al. Broad-range PCR as a supplement to culture for detection of bacterial pathogens in patients with a clinically diagnosed spinal infection. Scand J Infect Dis. 2008;40(10):772–777. doi: 10.1080/00365540802119994. [DOI] [PubMed] [Google Scholar]
  • 56.Delogu G, Zumbo A, Fadda G. Microbiological and immunological diagnosis of tuberculous spondylodiscitis. Eur Rev Med Pharmacol Sci. 2012;16(Suppl 2):73–78. [PubMed] [Google Scholar]
  • 57.Jevtic V. Vertebral infection. Eur Radiol. 2004;14(Suppl 3):E43–E52. doi: 10.1007/s00330-003-2046-x. [DOI] [PubMed] [Google Scholar]
  • 58.Ledermann HP, et al. MR imaging findings in spinal infections: rules or myths? Radiology. 2003;228(2):506–514. doi: 10.1148/radiol.2282020752. [DOI] [PubMed] [Google Scholar]
  • 59.Modic MT, et al. Vertebral osteomyelitis: assessment using MR. Radiology. 1985;157(1):157–166. doi: 10.1148/radiology.157.1.3875878. [DOI] [PubMed] [Google Scholar]
  • 60.Leone A, et al. Imaging of spondylodiscitis. Eur Rev Med Pharmacol Sci. 2012;16(Suppl 2):8–19. [PubMed] [Google Scholar]
  • 61.Diehn FE. Imaging of spine infection. Radiol Clin North Am. 2012;50(4):777–798. doi: 10.1016/j.rcl.2012.04.001. [DOI] [PubMed] [Google Scholar]
  • 62.Shah LM, Salzman KL. Imaging of spinal metastatic disease. Int J Surg Oncol. 2011;2011:769753. doi: 10.1155/2011/769753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Anley CM, Brandt AD, Dunn R. Magnetic resonance imaging findings in spinal tuberculosis: comparison of HIV positive and negative patients. Indian J Orthop. 2012;46(2):186–190. doi: 10.4103/0019-5413.93688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Kowalski TJ, et al. Follow-up MR imaging in patients with pyogenic spine infections: lack of correlation with clinical features. AJNR Am J Neuroradiol. 2007;28(4):693–699. [PMC free article] [PubMed] [Google Scholar]
  • 65.Carragee EJ. The clinical use of magnetic resonance imaging in pyogenic vertebral osteomyelitis. Spine (Phila Pa 1976) 1997;22(7):780–785. doi: 10.1097/00007632-199704010-00015. [DOI] [PubMed] [Google Scholar]
  • 66.Gemmel F, Dumarey N, Palestro CJ. Radionuclide imaging of spinal infections. Eur J Nucl Med Mol Imaging. 2006;33(10):1226–1237. doi: 10.1007/s00259-006-0098-2. [DOI] [PubMed] [Google Scholar]
  • 67.Gemmel F, et al. Expanding role of 18F-fluoro-d-deoxyglucose PET and PET/CT in spinal infections. Eur Spine J. 2010;19(4):540–551. doi: 10.1007/s00586-009-1251-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Kwon JW, et al. MRI findings of Aspergillus spondylitis. AJR Am J Roentgenol. 2011;197(5):W919–W923. doi: 10.2214/AJR.11.6786. [DOI] [PubMed] [Google Scholar]
  • 69.Currie S, et al. MRI characteristics of tuberculous spondylitis. Clin Radiol. 2011;66(8):778–787. doi: 10.1016/j.crad.2011.02.016. [DOI] [PubMed] [Google Scholar]
  • 70.James SL, Davies AM. Imaging of infectious spinal disorders in children and adults. Eur J Radiol. 2006;58(1):27–40. doi: 10.1016/j.ejrad.2005.12.002. [DOI] [PubMed] [Google Scholar]
  • 71.Zarghooni K, et al. Treatment of spondylodiscitis. Int Orthop. 2012;36(2):405–411. doi: 10.1007/s00264-011-1425-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Thwaites G, et al. British infection society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167–187. doi: 10.1016/j.jinf.2009.06.011. [DOI] [PubMed] [Google Scholar]
  • 73.van Ooij A, et al. Surgical treatment of aspergillus spondylodiscitis. Eur Spine J. 2000;9(1):75–79. doi: 10.1007/s005860050014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Friedman JA, et al. Spontaneous disc space infections in adults. Surg Neurol. 2002;57(2):81–86. doi: 10.1016/s0090-3019(01)00681-4. [DOI] [PubMed] [Google Scholar]
  • 75.Darley ES, MacGowan AP. Antibiotic treatment of gram-positive bone and joint infections. J Antimicrob Chemother. 2004;53(6):928–935. doi: 10.1093/jac/dkh191. [DOI] [PubMed] [Google Scholar]
  • 76.McHenry MC, Easley KA, Locker GA. Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis. 2002;34(10):1342–1350. doi: 10.1086/340102. [DOI] [PubMed] [Google Scholar]
  • 77.Nolla JM, et al. Spontaneous pyogenic vertebral osteomyelitis in nondrug users. Semin Arthritis Rheum. 2002;31(4):271–278. doi: 10.1053/sarh.2002.29492. [DOI] [PubMed] [Google Scholar]
  • 78.Baker AS, RG OJ, Baker RA. To decompress or not to decompress–spinal epidural abscess. Clin Infect Dis. 1992;15(1):28–29. doi: 10.1093/clinids/15.1.28. [DOI] [PubMed] [Google Scholar]
  • 79.Chen WH, Jiang LS, Dai LY. Surgical treatment of pyogenic vertebral osteomyelitis with spinal instrumentation. Eur Spine J. 2007;16(9):1307–1316. doi: 10.1007/s00586-006-0251-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Darouiche RO. Spinal epidural abscess. N Engl J Med. 2006;355(19):2012–2020. doi: 10.1056/NEJMra055111. [DOI] [PubMed] [Google Scholar]
  • 81.Yoshimoto M, et al. Pyogenic spondylitis in the elderly: a report from Japan with the most aging society. Eur Spine J. 2011;20(4):649–654. doi: 10.1007/s00586-010-1659-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Pola E, et al. Surgical treatment of tuberculous spondylodiscitis. Eur Rev Med Pharmacol Sci. 2012;16(Suppl 2):79–85. [PubMed] [Google Scholar]
  • 83.Linhardt O, et al. Long-term results of ventro-dorsal versus ventral instrumentation fusion in the treatment of spondylitis. Int Orthop. 2007;31(1):113–119. doi: 10.1007/s00264-006-0140-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Schinkel C, Gottwald M, Andress HJ. Surgical treatment of spondylodiscitis. Surg Infect (Larchmt) 2003;4(4):387–391. doi: 10.1089/109629603322761445. [DOI] [PubMed] [Google Scholar]
  • 85.Muckley T, et al. The role of thoracoscopic spinal surgery in the management of pyogenic vertebral osteomyelitis. Spine (Phila Pa 1976) 2004;29(11):E227–E233. doi: 10.1097/00007632-200406010-00023. [DOI] [PubMed] [Google Scholar]
  • 86.Lee JS, Suh KT. Posterior lumbar interbody fusion with an autogenous iliac crest bone graft in the treatment of pyogenic spondylodiscitis. J Bone Joint Surg Br. 2006;88(6):765–770. doi: 10.1302/0301-620X.88B6.17270. [DOI] [PubMed] [Google Scholar]
  • 87.Zhang HQ, et al. Two-stage surgical management using posterior instrumentation, anterior debridement and allografting for tuberculosis of the lower lumbar spine in children of elementary school age: minimum 3-year follow-up of 14 patients. Arch Orthop Trauma Surg. 2012;132(9):1273–1279. doi: 10.1007/s00402-012-1548-x. [DOI] [PubMed] [Google Scholar]
  • 88.Shousha M, Boehm H. Surgical treatment of cervical spondylodiscitis: a review of 30 consecutive patients. Spine (Phila Pa 1976) 2012;37(1):E30–E36. doi: 10.1097/BRS.0b013e31821bfdb2. [DOI] [PubMed] [Google Scholar]
  • 89.Masuda T, et al. Comparative study on the efficacy of two-staged (posterior followed by anterior) surgical treatment using spinal instrumentation on pyogenic and tuberculotic spondylitis. Arch Orthop Trauma Surg. 2011;131(6):765–772. doi: 10.1007/s00402-010-1209-x. [DOI] [PubMed] [Google Scholar]
  • 90.Koptan W, Elmiligui Y, Elsharkawi M. Single stage anterior reconstruction using titanium mesh cages in neglected kyphotic tuberculous spondylodiscitis of the cervical spine. Eur Spine J. 2011;20(2):308–313. doi: 10.1007/s00586-010-1537-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Erturer E, et al. The results of simultaneous posterior-anterior-posterior surgery in multilevel tuberculosis spondylitis associated with severe kyphosis. Eur Spine J. 2010;19(12):2209–2215. doi: 10.1007/s00586-010-1481-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Chen LH, et al. Surgical treatment of infectious spondylitis in patients undergoing hemodialysis therapy. Eur Spine J. 2010;19(12):2223–2228. doi: 10.1007/s00586-010-1501-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Hempelmann RG, Mater E, Schon R. Septic hematogenous lumbar spondylodiscitis in elderly patients with multiple risk factors: efficacy of posterior stabilization and interbody fusion with iliac crest bone graft. Eur Spine J. 2010;19(10):1720–1727. doi: 10.1007/s00586-010-1448-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Hirakawa A, et al. Surgical outcome of 2-stage (posterior and anterior) surgical treatment using spinal instrumentation for tuberculous spondylitis. J Spinal Disord Tech. 2010;23(2):133–138. doi: 10.1097/BSD.0b013e31819a870f. [DOI] [PubMed] [Google Scholar]
  • 95.Okada Y, et al. Clinical and radiological outcome of surgery for pyogenic and tuberculous spondylitis: comparisons of surgical techniques and disease types. J Neurosurg Spine. 2009;11(5):620–627. doi: 10.3171/2009.5.SPINE08331. [DOI] [PubMed] [Google Scholar]
  • 96.Zaveri GR, Mehta SS. Surgical treatment of lumbar tuberculous spondylodiscitis by transforaminal lumbar interbody fusion (TLIF) and posterior instrumentation. J Spinal Disord Tech. 2009;22(4):257–262. doi: 10.1097/BSD.0b013e31818859d0. [DOI] [PubMed] [Google Scholar]
  • 97.Lu DC, Wang V, Chou D. The use of allograft or autograft and expandable titanium cages for the treatment of vertebral osteomyelitis. Neurosurgery. 2009;64(1):122–129. doi: 10.1227/01.NEU.0000336332.11957.0B. [DOI] [PubMed] [Google Scholar]
  • 98.Robinson Y, et al. Successful treatment of spondylodiscitis using titanium cages: a 3-year follow-up of 22 consecutive patients. Acta Orthop. 2008;79(5):660–664. doi: 10.1080/17453670810016687. [DOI] [PubMed] [Google Scholar]
  • 99.Pee YH, et al. Anterior debridement and fusion followed by posterior pedicle screw fixation in pyogenic spondylodiscitis: autologous iliac bone strut versus cage. J Neurosurg Spine. 2008;8(5):405–412. doi: 10.3171/SPI/2008/8/5/405. [DOI] [PubMed] [Google Scholar]
  • 100.Korovessis P, et al. Beneficial influence of titanium mesh cage on infection healing and spinal reconstruction in hematogenous septic spondylitis: a retrospective analysis of surgical outcome of twenty-five consecutive cases and review of literature. Spine (Phila Pa 1976) 2008;33(21):E759–E767. doi: 10.1097/BRS.0b013e318187875e. [DOI] [PubMed] [Google Scholar]
  • 101.Hee HT, et al. Better treatment of vertebral osteomyelitis using posterior stabilization and titanium mesh cages. J Spinal Disord Tech. 2002;15(2):149–156. doi: 10.1097/00024720-200204000-00010. [DOI] [PubMed] [Google Scholar]
  • 102.Liljenqvist U, et al. Titanium cages in the surgical treatment of severe vertebral osteomyelitis. Eur Spine J. 2003;12(6):606–612. doi: 10.1007/s00586-003-0614-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Korovessis P, Repantis T, Hadjipavlou AG. Hematogenous pyogenic spinal infection: current perceptions. Orthopedics. 2012;35(10):885–892. doi: 10.3928/01477447-20120919-11. [DOI] [PubMed] [Google Scholar]
  • 104.Schuster JM, et al. Use of structural allografts in spinal osteomyelitis: a review of 47 cases. J Neurosurg. 2000;93(1 Suppl):8–14. doi: 10.3171/spi.2000.93.1.0008. [DOI] [PubMed] [Google Scholar]
  • 105.Dimar JR, et al. Treatment of pyogenic vertebral osteomyelitis with anterior debridement and fusion followed by delayed posterior spinal fusion. Spine (Phila Pa 1976) 2004;29(3):326–332. doi: 10.1097/01.brs.0000109410.46538.74. [DOI] [PubMed] [Google Scholar]
  • 106.Rihn JA, et al. The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis. Eur Spine J. 2009;18(11):1629–1636. doi: 10.1007/s00586-009-1046-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.O’Shaughnessy BA, Kuklo TR, Ondra SL. Surgical treatment of vertebral osteomyelitis with recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) 2008;33(5):E132–E139. doi: 10.1097/BRS.0b013e3181657ee3. [DOI] [PubMed] [Google Scholar]
  • 108.Allen RT, et al. Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis. Spine (Phila Pa 1976) 2007;32(26):2996–3006. doi: 10.1097/BRS.0b013e31815cde3e. [DOI] [PubMed] [Google Scholar]
  • 109.Jin D, et al. One-stage anterior interbody autografting and instrumentation in primary surgical management of thoracolumbar spinal tuberculosis. Eur Spine J. 2004;13(2):114–121. doi: 10.1007/s00586-003-0661-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Oga M, et al. Evaluation of the risk of instrumentation as a foreign body in spinal tuberculosis. Clinical and biologic study. Spine (Phila Pa 1976) 1993;18(13):1890–1894. doi: 10.1097/00007632-199310000-00028. [DOI] [PubMed] [Google Scholar]
  • 111.Benli IT, et al. Anterior radical debridement and anterior instrumentation in tuberculosis spondylitis. Eur Spine J. 2003;12(2):224–234. doi: 10.1007/s00586-002-0403-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Yilmaz C, et al. Anterior instrumentation for the treatment of spinal tuberculosis. J Bone Joint Surg Am. 1999;81(9):1261–1267. doi: 10.2106/00004623-199909000-00007. [DOI] [PubMed] [Google Scholar]
  • 113.Lu CH, et al. Adult spinal epidural abscess: clinical features and prognostic factors. Clin Neurol Neurosurg. 2002;104(4):306–310. doi: 10.1016/s0303-8467(02)00020-3. [DOI] [PubMed] [Google Scholar]
  • 114.Chen SH, et al. The clinical characteristics, therapeutic outcome, and prognostic factors of non-tuberculous bacterial spinal epidural abscess in adults: a hospital-based study. Acta Neurol Taiwan. 2011;20(2):107–113. [PubMed] [Google Scholar]
  • 115.Khanna RK, et al. Spinal epidural abscess: evaluation of factors influencing outcome. Neurosurgery. 1996;39(5):958–964. doi: 10.1097/00006123-199611000-00016. [DOI] [PubMed] [Google Scholar]
  • 116.Huang PY, et al. Spinal epidural abscess in adults caused by Staphylococcus aureus: clinical characteristics and prognostic factors. Clin Neurol Neurosurg. 2012;114(6):572–576. doi: 10.1016/j.clineuro.2011.12.006. [DOI] [PubMed] [Google Scholar]
  • 117.Tang HJ, et al. Spinal epidural abscess–experience with 46 patients and evaluation of prognostic factors. J Infect. 2002;45(2):76–81. doi: 10.1053/jinf.2002.1013. [DOI] [PubMed] [Google Scholar]
  • 118.Gonzalez-Lopez JJ, et al. Spontaneous epidural abscess: analysis of 15 cases with emphasis on diagnostic and prognostic factors. Eur J Intern Med. 2009;20(5):514–517. doi: 10.1016/j.ejim.2009.03.010. [DOI] [PubMed] [Google Scholar]
  • 119.Soehle M, Wallenfang T. Spinal epidural abscesses: clinical manifestations, prognostic factors, and outcomes. Neurosurgery. 2002;51(1):79–85. doi: 10.1097/00006123-200207000-00013. [DOI] [PubMed] [Google Scholar]
  • 120.Reihsaus E, Waldbaur H, Seeling W. Spinal epidural abscess: a meta-analysis of 915 patients. Neurosurg Rev. 2000;23(4):175–204. doi: 10.1007/pl00011954. [DOI] [PubMed] [Google Scholar]
  • 121.Bostrom A, et al. Treatment strategies and outcome in patients with non-tuberculous spinal epidural abscess–a review of 46 cases. Minim Invasive Neurosurg. 2008;51(1):36–42. doi: 10.1055/s-2007-1004547. [DOI] [PubMed] [Google Scholar]
  • 122.Rigamonti D, et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol. 1999;52(2):189–196. doi: 10.1016/s0090-3019(99)00055-5. [DOI] [PubMed] [Google Scholar]

Articles from European Spine Journal are provided here courtesy of Springer-Verlag

RESOURCES